Variant report
Variant | nsv965215 |
---|---|
Chromosome Location | chr3:138800265-138808614 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr3:138803435-138803529 | Kidney_OC | kidney: | n/a | n/a |
2 | CTCF | chr3:138807355-138807406 | GM20000 | blood: | n/a | n/a |
3 | E2F4 | chr3:138808390-138808512 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | MAFF | chr3:138802728-138802995 | K562 | blood: | n/a | chr3:138802815-138802833 |
5 | MAFF | chr3:138802676-138802922 | HepG2 | liver: | n/a | chr3:138802815-138802833 |
6 | MAFK | chr3:138802660-138802922 | HepG2 | liver: | n/a | n/a |
7 | MAFK | chr3:138802670-138802994 | HepG2 | liver: | n/a | n/a |
8 | POLR2A | chr3:138807567-138807841 | MCF-7 | breast: | n/a | n/a |
9 | POLR2A | chr3:138807547-138807565 | MCF-7 | breast: | n/a | n/a |
10 | POLR2A | chr3:138800831-138801027 | GM12878 | blood: | n/a | n/a |
11 | POLR2A | chr3:138807842-138808127 | MCF-7 | breast: | n/a | n/a |
12 | POLR2A | chr3:138808429-138808488 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | POLR2A | chr3:138807610-138807674 | Gliobla | brain: | n/a | n/a |
14 | POLR2A | chr3:138807692-138807738 | Gliobla | brain: | n/a | n/a |
15 | STAT3 | chr3:138803329-138803474 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:138808358..138809864-chr3:139107100..139108975,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL7L1P7 | TF binding region |
ENSG00000252245 | chromatin interactions |
ENSG00000248932 | chromatin interactions |
ENSG00000184432 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561823193 | chr3:138802678-138802679 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs542613903 | chr3:138802728-138802729 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs149365536 | chr3:138802742-138802743 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs576586253 | chr3:138802780-138802781 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs542396380 | chr3:138802832-138802833 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs371806271 | chr3:138802833-138802834 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs79177273 | chr3:138802843-138802844 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs565068109 | chr3:138802875-138802876 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs187793071 | chr3:138803372-138803373 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs68129305 | chr3:138803442-138803443 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs556270476 | chr3:138803464-138803465 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs79748096 | chr3:138803510-138803511 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs201824936 | chr3:138807614-138807615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs370247580 | chr3:138807617-138807618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1851265 | chr3:138807620-138807621 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs1849107 | chr3:138807648-138807649 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs113864993 | chr3:138807677-138807678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs3072563 | chr3:138807678-138807679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs201225957 | chr3:138807679-138807680 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562102921 | chr3:138807709-138807710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553704485 | chr3:138807735-138807736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138490099 | chr3:138807806-138807807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547662986 | chr3:138807968-138807969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs555117309 | chr3:138808400-138808401 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
25 | rs568872240 | chr3:138808431-138808432 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
26 | rs537799516 | chr3:138808482-138808483 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
27 | rs141376198 | chr3:138808495-138808496 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
28 | rs182574048 | chr3:138808560-138808561 | Inactive region | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Lung cancer | 16740712 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Developmental delay | 21147756 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
abnormal development | 18461090 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:138807600-138808000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |